SCHEMBL19600401

SCHEMBL19600401

c1cncc(-c2ccc3c(c2)Oc2cccc4c(-c5ccc(-c6cccc7ccccc67)cc5)ccc-3c24)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.46
ALDH1A1 P00352 2/20 0.46
MAPT P10636 2/20 0.46
HPGD P15428 2/20 0.46
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
CYP11B1 P15538 5/20 0.44
CYP11B2 P19099 4/20 0.44
CYP17A1 P05093 1/20 0.44
CYP19A1 P11511 1/20 0.44
TNF P01375 1/20 0.43
MAPK1 P28482 1/20 0.40
ATM Q13315 1/20 0.40
PIK3CA P42336 1/20 0.39
PGR P06401 1/20 0.39
BACE1 P56817 1/20 0.38
KCNH2 Q12809 1/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17265385 0.91 CYP11B1 (0.44) KDM4EALDH1A1MAPTHPGDRAB9A
SCHEMBL19600426 0.89 CYP11B1 (0.41) KDM4EALDH1A1MAPTHPGDRAB9A
SCHEMBL19600402 0.87 KDM4E (0.47) KDM4EALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL18012342 0.87 MAPK1 (0.50) KDM4EALDH1A1HPGDRAB9AMAPK1
SCHEMBL19600405 0.85 KDM4E (0.49) KDM4EALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL16376392 0.84 KDM4E (0.47) KDM4EALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL17886385 0.82 KDM4E (0.39) KDM4EALDH1A1MAPTHPGDRAB9A
SCHEMBL16376421 0.81 CYP11B1 (0.41) KDM4EALDH1A1MAPTHPGDRAB9A
SCHEMBL19600420 0.81 KDM4E (0.44) KDM4EALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL16376372 0.80 KDM4E (0.43) KDM4EALDH1A1MAPTHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023096225-A1 HETEROCYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE AND COMPOSITION FOR FORMING ORGANIC MATERIAL LAYER, COMPRISING SAME 엘티소재주식회사 2023-06-01 WO disclosed
US-10573825-B2 Compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-25 US disclosed
US-20170331051-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-16 US disclosed
US-20170331051-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10573825-B2 Compound and organic light-emitting device including the same CRY1, CRY2, AOX1 KDM4E 2074/4885ALDH1A1 7/4885MAPT 1125/4885
US-20170331051-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, AOX1 KDM4E 2074/4885ALDH1A1 7/4885MAPT 1125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.